Amgen Postdoctoral Program
Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A leader in biotechnology since 1980, Amgen was one of the first companies to realize the new science’s promise by bringing safe, effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses.
Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology, and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness. You can read more about Amgen at http://www.amgen.com.
The Amgen Postdoctoral Program is committed to providing future scientists with an enriched environment to inspire innovation that will contribute to the development of human therapeutics.
This is one of the two positions supporting Aimovig, Amgen’s CGRP (calcitonin gene-related peptide) receptor Ab for migraine prevention, current under FDA review for BLA (Biologic License Application). We will be studying system biology as well as migraine pathophysiology using ex vivo electrophysiology approaches.
The focus of this project is the trigeminal ganglion to brainstem signal transmission and the impact of CGRP pathway inhibitors to the aforementioned signaling. Manuscript publication and meeting presentations will occur immediately with the outcomes of the study.
The assignment length is expected to be 3 years long.
PhD at the time of appointment
Skilled in designing complex ex vivo electrophysiology experiments and interpreting results.
The candidate should have robust training and technical skills that include: dissecting and isolating tissues, inserting probes into desired brain regions, setting up and manipulating input signals and recording output activities
Christine Geary MBA, PHR
Talent Acquisition Consultant
CGeary@Amgen.com | 1 805 313 8572
Thousand Oaks, CA
Amgen ranks as one of Fortune’s World’s Most Admired Companies – Pharmaceutical Sector: http://for.tn/1lD66n0
The Shape of Drugs to Come - http://bit.ly/1VTUCvO